Lausanne, Switzerland
Adaptyv, founded in 2020, is spearheading innovation in the Biotechnology and Pharmaceutical industries from its headquarters in Switzerland. Known as "The cloud lab for protein designers," Adaptyv focuses on creating a next-generation protein foundry. This technology enables the synthesis and testing of custom-designed proteins, positioning the company at the forefront of advanced nanotechnology applications.
Recently, Adaptyv secured a Fr.6.40M Series A investment on 01 October 2025. The funding round was backed by notable investors such as byFounders, Founderful, ACE Ventures, and LongGame. The investment highlights strong market confidence in Adaptyv's potential to revolutionize protein design solutions.
For investors, Adaptyv represents a promising opportunity characterized by cutting-edge technology and robust financial backing, geared to address growing demands in biotechnology and pharmaceutical developments.
Amai Proteins